AzTrials
AzTrials

Specific Learning DisorderNCT07054164

Effect of Dual-Task Aerobic Exercise on Children With Specific Learning Disorder

A study testing dual-task aerobic exercise and aerobic exercise in people with Specific Learning Disorder, run by Bezmialem Vakif University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the present study is to investigate the effects of dual-task aerobic exercise training on attention, balance, and quality of life in children with Specific Learning Disorder. Read more about this study

Who is it for?
Ages 7 to 14 years
Conditions the study is for
Specific Learning Disorder
What is being tested?
dual-task aerobic exercise and aerobic exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteTurkey (Türkiye)
Study dates
26 Sep 2023to 7 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 14 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Diagnosed with a specific learning disorder according to DSM-V criteria
  • Being between the ages of 6-14
  • Having reading skills
  • Not having received treatment for a specific learning disorder

Who cannot join

  • Having a chronic and serious systemic disease
  • Having a seizure-like neurological disorder
  • Having vision, speech and hearing problems
  • Not attending the individual education program regularly
  • Having any contraindications for physical exercise

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Bezmialem Vakıf University, Institute of Health Sciences, Department of Physiotherapy and Rehabilitation, Istanbul, TR

    Istanbul, Fatih, 34093

Other trials in Turkey (Türkiye)

About this study

Official title: Effects of Dual-Task Aerobic Exercise Training on Attention, Balance, and Quality of Life in Children With Specific Learning Disorder

The aim of the present study is to investigate the effects of dual-task aerobic exercise training on attention, balance, and quality of life in children with Specific Learning Disorder.

Read the detailed description

Specific Learning Disorder is a neurodevelopmental condition characterized by difficulties in basic academic skills such as reading, writing, language comprehension, mathematical calculations, and information processing, despite normal or above-normal intellectual capacity.

Although the primary difficulties experienced by individuals diagnosed with Specific Learning Disorder involve impairments in acquiring academic skills such as learning and performing mathematical calculations, various deficiencies have also been observed in physical domains such as balance and motor coordination.

No previous studies have been identified in the literature examining the effects of dual-task focused aerobic exercises on individuals diagnosed with Specific Learning Disorder. The investigators hypothesize that dual-task focused aerobic exercise training administered to children with Specific Learning Disorder will have positive effects on attention, balance, and quality of life.

Being tested
dual-task aerobic exercise, aerobic exercise
Keywords
Specific Learning Disorder, Aerobic Exercise
Medical subject headings
Specific Learning Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • dual-task aerobic exerciseOther

    In addition to aerobic training during treadmill walks, participants were given some cognitive tasks and were asked to continue these tasks throughout the exercise.

  • aerobic exerciseOther

    Aerobic training with a treadmill at medium-high intensity, 3 days a week, for 8 weeks, accompanied by a physiotherapist

Study groups in NCT07054164
Study groupRoleWhat they receive
dual-task aerobic exercise groupOther3 days a week, 50 minutes (10 warm-ups, 30 minutes of moderate-high intensity walking, 10 minutes of cooling down) moderate-high intensity treadmill aerobic training was provided under the supervision of a physiotherapist. In addition to aerobic training, some cognitive tasks were given to the participants during the treadmill walks.
Receives: Other: dual-task aerobic exercise
aerobic exercise groupOther3 days a week, 50 minutes (10 warm-ups, 30 minutes of moderate-high intensity walking, 10 minutes of cooling down) moderate-high intensity treadmill aerobic training was provided under the supervision of a physiotherapist.
Receives: Other: aerobic exercise
control groupNo interventionno intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Stroop Test TBAG Form

    The Stroop Test TBAG Form is a neuropsychological test that evaluates complex attention, focused and selective attention, resistance to disruptive stimuli, cognitive inhibition, information processing speed and executive functions.

    Unit of Measure: Points

    Measured: 8 weeks

Secondary outcomes (7)
  1. Pediatric Balance Scale (PDS)

    The scale consists of 14 sections in total and each section is evaluated and scored between 0-4 points. The total score gives the PDS score. The score range of the scale is between 0-56 and higher scores indicate better balance performance.

    Measured: 8 weeks

  2. Biodex Balance System

    The Biodex Balance System is an equipment that can be used for both objective assessment of postural balance and balance training. The device consists of a screen, a circular balance platform, arm support and a printer.

    Measured: 8 weeks

  3. Quality of Life Inventory for Children (PedsQL)

    It is a scale used to evaluate the general quality of life of children aged 2-18; it consists of a total of 23 items that question children's physical, emotional, psychosocial and school-related problems, and each item is scored between 0-100.

    Measured: 8 weeks

  4. Body composition measurement

    The Omron BF511 Body Composition Monitor® non-invasive body composition measurement device, which works with the 4-pole bioelectrical impedance method (determines the ratio of fat and muscle tissue in the body with a weak electric current passing through the body), was used to calculate the participants' skeletal muscle mass ratio (%), body fat ratio (%) and basal metabolic rate.

    Measured: 8 weeks

  5. Body Weight Measurement

    Body weight will be measured using a digital scale with participants wearing light clothing and no shoes.

    Unit of Measure: Kilograms (kg)

    Measured: 8 weeks

  6. Height Measurement

    Height will be measured using a stadiometer with participants standing upright without shoes, heels together, and head in the Frankfurt plane.

    Unit of Measure: Meters (m)

    Measured: 8 weeks

  7. Body Mass Index (BMI)

    BMI will be calculated using the formula: weight in kilograms divided by the square of height in meters (kg/m²).

    Unit of Measure: Kilograms per square meter (kg/m²)

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jul 2025
  2. Study start26 Sep 2023
  3. Primary completion5 Feb 2025
  4. Study completion7 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants were divided into three groups: a dual-task aerobic exercise group, an aerobic exercise group, and a control group.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07054164
Sponsor's protocol ID
BVU-FTR-HRC-01
Status last verified
Jul 2025
First submitted
16 Jun 2025
Last updated
8 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing dual-task aerobic exercise and aerobic exercise in people with Specific Learning Disorder, run by Bezmialem Vakif University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Stroop Test TBAG Form (time frame: 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in